Optic neuritis
Methodology & AI Transparency ⓘ
Optic neuritis Key Takeaways
Translated by Sarah Jenkins (AI RN Plain-English Translator) at a 7th-grade reading level
- 1 What it does: Cataloged under federal diagnostic code H46.9 in Eyes & Vision, Optic neuritis requires AREDS2 macular nutrition [Optic neuritis H46.9] so specialists can calibrate treatment intensity against Best-Corrected Visual Acuity in Optic neuritis (H46.9: & OCT) benchmarks.
- 2 Real-world patient consensus: Diagnostic registry H46.9: Optic neuritis is managed within Eyes & Vision.
- 3 Typical cash cost range: Differential triage of Optic neuritis (H46.9) utilizes AREDS2 macular nutrition [Optic neuritis H46.9].
- 4 Top reported side effects / signs: Objective lab/clinical target for Optic neuritis: Best-Corrected Visual Acuity in Optic neuritis (H46.9: & OCT) (Intact retinal nerve fiber & macula (H46.9)) and HbA1c & Systemic in Optic neuritis (H46.9: Blood Pressure).
Ask our AI Specialists anything about Optic neuritis
What Is Optic neuritis?
Cataloged under federal diagnostic code H46.9 in Eyes & Vision, Optic neuritis requires AREDS2 macular nutrition [Optic neuritis H46.9] so specialists can calibrate treatment intensity against Best-Corrected Visual Acuity in Optic neuritis (H46.9: & OCT) benchmarks.
Pathophysiology, Underlying Causes & Clinical Presentation
Pathophysiologically, Optic neuritis (ICD-10 H46.9) is driven by retinal pigment epithelium in Optic neuritis (H46.9: oxidative drusen accumulation); specialists in Eye Health, Glaucoma & Vision Disorders monitor HbA1c & Systemic in Optic neuritis (H46.9: Blood Pressure) to gauge tissue recovery.
Common Symptoms & Clinical Signs
- • Presentation of Optic neuritis (H46.9): gritty burning, foreign-body in Optic neuritis (H46.9: sensation, reflex tearing,)
- • Secondary Optic neuritis clinical sign: loss of peripheral in Optic neuritis (H46.9: side vision)
- • Symptom flares in Optic neuritis correlating with Best-Corrected Visual Acuity in Optic neuritis (H46.9: & OCT) deviation outside Intact retinal nerve fiber & macula (H46.9)
- • Functional eyes & vision impact requiring AREDS2 macular nutrition [Optic neuritis H46.9] evaluation (H46.9)
Primary Federal Reference: NIH / National Library of Medicine MedlinePlus Entry ↗
Optic neuritis Diagnostic Classification & Lab Markers
| Metric | Verified Benchmark | Source |
|---|---|---|
| ICD-10-CM Diagnostic Code | H46.9 | WHO / CMS ICD-10-CM Clinical Classification |
| Clinical Specialty Hub | Eye Health, Glaucoma & Vision Disorders | NIH MedlinePlus Health Topics |
| Diagnostic / Lab Marker: Best-Corrected Visual Acuity in Optic neuritis (H46.9: & OCT) | Intact retinal nerve fiber & macula (H46.9) | Clinical Reference Target Range |
| Diagnostic / Lab Marker: HbA1c & Systemic in Optic neuritis (H46.9: Blood Pressure) | Microvascular retinal protection (H46.9) | Clinical Reference Target Range |
| Diagnostic / Lab Marker: Intraocular Pressure (IOP) [Optic neuritis H46.9] | 10 – 21 mmHg (individualized optic target) (H46.9) | Clinical Reference Target Range |
FDA-Monographed Medications & Public Cash Price Reference for Optic neuritis
| Medication | Pharmacologic Class | Patient Worth-It | CMS NADAC / Unit | Typical Lowest Cash |
|---|---|---|---|---|
| Rohto Optic Glow (Naphazoline Hydrochloride, Povidone, Propylene Glycol) Rohto Optic Glow • RxCUI 2531299 | Over-the-Counter Clinical Monograph | 75% | $2.2200 | $ 168.34 /mo |
Peer-Reviewed Human Clinical Trials & Meta-Analyses (Optic neuritis)
| Study & Plain-English Finding | Sample (N) | Rigor | Primary Source |
|---|---|---|---|
| New Insights on Benefits and safety of HSK3486 for Anesthesia/Sedation in Patients Undergoing: What a 267-Participant Study Found HSK3486 exhibited non-inferiority anesthesia/sedation compared to propofol in patients undergoing fiberoptic bronchoscopy, and had a good safety profile with a lower incidence of pain on injection. CNS drugs • 2022-03-15 • Phase III Randomized Trial | N = 267 | 93/100 | PMID 35157236 ↗ |
| Can This Approach Help? Inside the Latest Research on Exploring steroid tapering in patients with neuromyelitis optica spectrum During the OLE of SAkuraSky, 16 patients tapered steroids and the ARR did not increase from the DB period. Multiple sclerosis and related disorders • 2022-05-15 • Phase III Randomized Trial | N = 16 | 88/100 | PMID 35537314 ↗ |
| Can This Approach Help? Inside the Latest Research on Intravenous immunoglobulin treatment for steroid-resistant optic neuritis: a Our results suggest that intravenous immunoglobulin could be a safe and efficacious therapeutic option for prompt treatment of steroid-resistant acute ON. Japanese journal of ophthalmology • 2021-01-15 • Phase III Randomized Trial | Multi-cohort | 88/100 | PMID 33469728 ↗ |
| New Insights on Longitudinal Prediction of Retinal Sensitivity Based on Disease Progression: What a 406-Participant Study Found Two exploratory endpoints were developed, namely quantification of EZ thickness and loss, and localized RS within high-risk OCT areas. Investigative ophthalmology & visual science • 2026-09-01 • Phase III Randomized Trial | N = 406 | 87/100 | PMID 42742213 ↗ |
| New Insights on Phenomapping-derived selection of fractional flow reserve or optical coherence: What a 405-Participant Study Found Compared with a functional assessment, an OCT-based approach reduces revascularisation in patients with STEMI/NSTEMI, while FFR proved non-inferior for patients with stable angina. Open heart • 2025-09-17 • Phase III Randomized Trial | N = 405 | 87/100 | PMID 40967674 ↗ |
Optic neuritis Patient Community & “People Like Me” Threads
Filter Optic neuritis community threads and patient logs by age, biological sex, dosage, and treatment duration.